Phenyl-substituted analogs of oxotremorine as muscarinic antagonists

A series of phenyl-substituted analogues of the muscarinic agent oxotremorine (1) have been prepared. The new compounds (3b-11b and 9c) were assayed for antimuscarinic activity on the isolated guinea pig ileum and in intact mice. They were also evaluated for ability to inhibit the binding of the mus...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 35; no. 2; pp. 285 - 294
Main Authors Nilsson, Bjoern M, Vargas, Hugo M, Ringdahl, Bjoern, Hacksell, Uli
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 01.01.1992
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A series of phenyl-substituted analogues of the muscarinic agent oxotremorine (1) have been prepared. The new compounds (3b-11b and 9c) were assayed for antimuscarinic activity on the isolated guinea pig ileum and in intact mice. They were also evaluated for ability to inhibit the binding of the muscarinic antagonist (-)-[H-3]-N-methylscopolamine to homogenates of the rat cerebral cortex. The phenyl-substituted derivatives were devoid of intrinsic muscarinic activity. Instead, they behaved as competitive muscarinic antagonists in these assays with similar or lower affinity for muscarinic receptors than the corresponding methyl-substituted analogues. The succinimide (8b) and the pyrrolidone (3b) derivatives of 1 substituted with a phenyl group at position 1 of the butynyl chain showed the highest antimuscarinic potency with dissociation constants (K(D)) of 0.10 and 0.20-mu-M, respectively, in the ileum assay. The phenyl-substituted analogues showed an approximately 10-fold lower in vivo antimuscarinic potency than their corresponding methyl-substituted positional isomers. A correlation was observed between in vitro and in vivo potency within subsets consisting of methyl- and phenyl-substituted derivatives.
Bibliography:ark:/67375/TPS-BGT4XHG1-4
istex:041670B97434870F7B5B1B96A590773E8062DBB7
Medline
NIH RePORTER
ISSN:0022-2623
1520-4804
DOI:10.1021/jm00080a013